pharmexec.com
/3 weeks ago
Latest updates for Lavipharm
Fresh curated links around LAVIPHARM are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- <![CDATA[FDA Extends Priority Review of Leqembi Iqlik Subcutaneous Injection ]]>
- Ο επιχειρηματίας που σε πέντε χρόνια «έχτισε» ένα story αξίας 250 εκατ. ευρώ
- <![CDATA[Pharmaceutical Executive Daily: FDA Approves Auvelity]]>
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
naftemporiki.gr
/1 month ago
Ο επιχειρηματίας που σε πέντε χρόνια «έχτισε» ένα story αξίας 250 εκατ. ευρώ
Εάν κάτι λατρεύει η αγορά, αυτό είναι το… story. Και ο Τηλέμαχος Λαβίδας φαίνεται να γνωρίζει πολύ καλά αυτήν την προτίμηση, φροντίζοντας να προσφέρει στους επενδυτές την προοπτική...
pharmexec.com
/4 weeks ago
<![CDATA[Pharmaceutical Executive Daily: FDA Approves Auvelity]]>
pharmexec.com
/1 month ago
<![CDATA[Haisco Enters $745 Million Exclusive License Agreement with AbbVie ]]>
pharmexec.com
/2 weeks ago
<![CDATA[Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu]]>
pharmexec.com
/1 week ago
<![CDATA[Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio]]>
pharmexec.com
/1 month ago
<![CDATA[Teva Enters $900 Million Agreement to Acquire Emalex]]>
ekathimerini.com
/4 weeks ago
A European pharma hub will rise in Tripoli
Investment of €500 million in three factories by DEMO, Win Medica (of the ELPEN group) and FARAN.
pharmexec.com
/1 week ago
<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio]]>
pharmexec.com
/3 weeks ago
<![CDATA[Angelini Pharma Enters $ 4.1 Billion Agreement to Acquire Catalyst Pharmaceuticals ]]>
pharmexec.com
/1 month ago
<![CDATA[Eli Lilly Enters $ 2.3 Billion Agreement to Acquire Ajax Therapeutics ]]>
pharmexec.com
/1 month ago
<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics]]>
pharmexec.com
/1 week ago
<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Ther...
pharmexec.com
/1 month ago
<![CDATA[Biogen Enters $5.6 Billion Agreement to Acquire Apellis Pharmaceuticals ]]>
pharmexec.com
/3 weeks ago
<![CDATA[Pharmaceutical Executive Daily: Angelini Pharma Acquires Catalyst Pharmaceuticals in $4.1 Billion Agreement]...
pharmexec.com
/1 month ago
<![CDATA[Travere Therapeutics’ Filspari Receives Full FDA Approval ]]>
pharmexec.com
/2 weeks ago
<
pharmexec.com
/1 month ago
<![CDATA[Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics ]]>
pharmexec.com
/2 weeks ago
<![CDATA[Pharmaceutical Executive: May 2026 Interactive Digital Edition]]>
pharmexec.com
/1 month ago
<![CDATA[Pharmaceutical Executive: April 2026 Interactive Digital Edition]]>
pharmexec.com
/2 days ago
<![CDATA[Pharmaceutical Executive Daily: CVS Health to Offer Zepbound and Foundayo]]>
pharmexec.com
/1 month ago
<![CDATA[Gilead Enters $5 Billion Agreement to Acquire Tubulis ]]>
pharmexec.com
/1 month ago
<![CDATA[Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request ]]>
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Lavipharm
feeds.feedburner.com
Recent coverage from public sources
Public source
naftemporiki.gr
Recent coverage from public sources
Public source
pharmexec.com
Recent coverage from public sources
Public source